Analysts expect Instil Bio, Inc. to report revenue of 0.00 for Q4 25, against a range of 0.00 to 0.00. The most recent reported quarter, Q3 25, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||||
| High Estimate | 2.07 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Low Estimate | 1.93 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Consensus Estimate | 2.00 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Instil Bio, Inc. to report earnings per share of -0.16 for Q3 26, against a range of -0.18 to -0.14. The most recent reported quarter, Q2 26, came in at -0.63, a 85.3% miss against the -0.34 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.54 | -1.82 | -4.32 | -3.24 | -2.01 | -1.21 | -0.62 | -0.63 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -1.87 | -3.08 | -2.44 | -2.38 | -2.32 | -1.95 | -0.58 | -0.31 | -0.14 | -0.04 | -2.23 | -2.11 | -1.90 | -1.85 | -3.17 | -2.53 | ||||||
| Low Estimate | -2.19 | -3.70 | -2.88 | -2.84 | -2.70 | -2.29 | -0.68 | -0.37 | -0.18 | -0.04 | -2.55 | -2.47 | -2.08 | -2.03 | -3.41 | -2.81 | ||||||
| Consensus Estimate | -2.03 | -3.39 | -2.66 | -2.61 | -2.51 | -2.12 | -0.63 | -0.34 | -0.16 | -0.04 | -2.39 | -2.29 | -1.99 | -1.94 | -3.29 | -2.67 |